SK pharmteco has announced the successful CGMP qualification of its manufacturing facility in Corbeil-Essonnes, France, which is now fully operational and prepared to support late-stage and commercial viral vector programs at scale. Recently, the facility was inspected by the ANSM (French Health Authority) and was successfully approved for operations. It has since produced its first batch using the company’s proprietary AAVelocity platform. “The qualification of this new facility marks a c...